Literature DB >> 20129190

Rationale for treatment and therapeutic options in Cushing's disease.

Paul M Stewart1, Stephan Petersenn.   

Abstract

Cushing's disease results from prolonged overexposure of tissues to endogenous glucocorticoids, secondary to adrenocorticotrophin excess from the pituitary. Common clinical signs and symptoms include weight gain, hypertension, and osteoporosis. Effective treatment of Cushing's disease can normalize biochemical levels, reverse comorbidities, and improve overall survival and quality of life. Treatment options include pituitary or adrenal surgery, radiotherapy, and various medical therapies, but each has important limitations. Medical therapies that effectively target the pituitary tumour are urgently needed. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20129190     DOI: 10.1016/S1521-690X(09)70004-1

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  5 in total

Review 1.  Molecular basis of pharmacological therapy in Cushing's disease.

Authors:  Diego Ferone; Claudia Pivonello; Giovanni Vitale; Maria Chiara Zatelli; Annamaria Colao; Rosario Pivonello
Journal:  Endocrine       Date:  2013-11-23       Impact factor: 3.633

Review 2.  Pituitary-directed medical therapy in Cushing's disease.

Authors:  Stephan Petersenn; Maria Fleseriu
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

3.  ACTH-secreting pituitary adenomas: size does not correlate with hormonal activity.

Authors:  Nestoras Mathioudakis; Courtney Pendleton; Alfredo Quinones-Hinojosa; Gary S Wand; Roberto Salvatori
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

Review 4.  The Metabolic Implications of Glucocorticoids in a High-Fat Diet Setting and the Counter-Effects of Exercise.

Authors:  Emily C Dunford; Michael C Riddell
Journal:  Metabolites       Date:  2016-12-05

5.  Broad Metabolome Alterations Associated with the Intake of Oral Contraceptives Are Mediated by Cortisol in Premenopausal Women.

Authors:  Clara Eick; Johanna Klinger-König; Stephanie Zylla; Anke Hannemann; Kathrin Budde; Ann Kristin Henning; Maik Pietzner; Matthias Nauck; Henry Völzke; Hans J Grabe; Johannes Hertel
Journal:  Metabolites       Date:  2021-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.